Jan Van Droogenbroeck
- Hematology top 2%
- Genetics top 2%
- Rheumatology top 5%
- Oncology
- Molecular Biology
- Co-authors
- Michele BaccaraniM. Brigid Bradley‐GarelikChao ZhuAndreas HochhausTadeusz RobakCarolina PavlovskyJörge E. CortesMichinori Ogura
- Topics
- Multiple Myeloma Research and Treatments (7 papers)Chronic Lymphocytic Leukemia Research (6 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- BelgiumUnited StatesPortugal
In The Last Decade
Jan Van Droogenbroeck
28 papers receiving 771 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Hematology 507
- Genetics 401
- Rheumatology 234
- Oncology 173
- Molecular Biology 158
Countries citing papers authored by Jan Van Droogenbroeck
This map shows the geographic impact of Jan Van Droogenbroeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Van Droogenbroeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Van Droogenbroeck more than expected).
Fields of papers citing papers by Jan Van Droogenbroeck
This network shows the impact of papers produced by Jan Van Droogenbroeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Van Droogenbroeck. The network helps show where Jan Van Droogenbroeck may publish in the future.
Co-authorship network of co-authors of Jan Van Droogenbroeck
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Van Droogenbroeck. A scholar is included among the top collaborators of Jan Van Droogenbroeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Van Droogenbroeck. Jan Van Droogenbroeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 32 | |
| 7 | 42 | |
| 8 | 6 | |
| 9 | 27 | |
| 10 | 9 | |
| 11 | 4 | |
| 12 | Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)breakdown → | 441 |
| 13 | 27 | |
| 14 | 66 | |
| 15 | 7 | |
| 16 | 17 | |
| 17 | 12 | |
| 18 | 4 | |
| 19 | 36 | |
| 20 | 2 |
About Jan Van Droogenbroeck
Jan Van Droogenbroeck is a scholar working on Hematology, Genetics and Nephrology, having authored 31 papers that have together received 789 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (507 citations), Genetics (401 citations) and Rheumatology (234 citations). Jan Van Droogenbroeck has collaborated with scholars based in Belgium, United States and Portugal. Frequent co-authors include Michele Baccarani, M. Brigid Bradley‐Garelik, Chao Zhu, Andreas Hochhaus, Tadeusz Robak, Carolina Pavlovsky, Jörge E. Cortes, Michinori Ogura, Neil P. Shah and Dong‐Wook Kim. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.